160 related articles for article (PubMed ID: 32033353)
1. The Kinetics of Amyloid Fibril Formation by
Balobanov V; Chertkova R; Egorova A; Dolgikh D; Bychkova V; Kirpichnikov M
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32033353
[TBL] [Abstract][Full Text] [Related]
2. Amyloidogenic properties of the artificial protein albebetin and its biologically active derivatives. The role of electrostatic interactions in fibril formation.
Lavrikova MA; Zamotin VV; Malisauskas M; Chertkova RV; Kostanyan IA; Dolgikh DA; Kirpichnikov MP; Morozova-Roche LA
Biochemistry (Mosc); 2006 Mar; 71(3):306-14. PubMed ID: 16545068
[TBL] [Abstract][Full Text] [Related]
3. Optimum amyloid fibril formation of a peptide fragment suggests the amyloidogenic preference of beta2-microglobulin under physiological conditions.
Ohhashi Y; Hasegawa K; Naiki H; Goto Y
J Biol Chem; 2004 Mar; 279(11):10814-21. PubMed ID: 14699107
[TBL] [Abstract][Full Text] [Related]
4. Fibrillation of carrier protein albebetin and its biologically active constructs. Multiple oligomeric intermediates and pathways.
Morozova-Roche LA; Zamotin V; Malisauskas M; Ohman A; Chertkova R; Lavrikova MA; Kostanyan IA; Dolgikh DA; Kirpichnikov MP
Biochemistry; 2004 Aug; 43(30):9610-9. PubMed ID: 15274615
[TBL] [Abstract][Full Text] [Related]
5. Aggregation and fibril morphology of the Arctic mutation of Alzheimer's Aβ peptide by CD, TEM, STEM and in situ AFM.
Norlin N; Hellberg M; Filippov A; Sousa AA; Gröbner G; Leapman RD; Almqvist N; Antzutkin ON
J Struct Biol; 2012 Oct; 180(1):174-89. PubMed ID: 22750418
[TBL] [Abstract][Full Text] [Related]
6. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates.
Khurana R; Gillespie JR; Talapatra A; Minert LJ; Ionescu-Zanetti C; Millett I; Fink AL
Biochemistry; 2001 Mar; 40(12):3525-35. PubMed ID: 11297418
[TBL] [Abstract][Full Text] [Related]
7. Ultrasonication-induced amyloid fibril formation of beta2-microglobulin.
Ohhashi Y; Kihara M; Naiki H; Goto Y
J Biol Chem; 2005 Sep; 280(38):32843-8. PubMed ID: 16046408
[TBL] [Abstract][Full Text] [Related]
8. Engineering amyloid fibrils from β-solenoid proteins for biomaterials applications.
Peralta MD; Karsai A; Ngo A; Sierra C; Fong KT; Hayre NR; Mirzaee N; Ravikumar KM; Kluber AJ; Chen X; Liu GY; Toney MD; Singh RR; Cox DL
ACS Nano; 2015 Jan; 9(1):449-63. PubMed ID: 25562726
[TBL] [Abstract][Full Text] [Related]
9. Amyloid fibrils formation and amorphous aggregation in concanavalin A.
Vetri V; Canale C; Relini A; Librizzi F; Militello V; Gliozzi A; Leone M
Biophys Chem; 2007 Jan; 125(1):184-90. PubMed ID: 16934387
[TBL] [Abstract][Full Text] [Related]
10. Systematic analysis of aggregates from 38 kinds of non disease-related proteins: identifying the intrinsic propensity of polypeptides to form amyloid fibrils.
Aso Y; Shiraki K; Takagi M
Biosci Biotechnol Biochem; 2007 May; 71(5):1313-21. PubMed ID: 17485839
[TBL] [Abstract][Full Text] [Related]
11. Competition between crystal and fibril formation in molecular mutations of amyloidogenic peptides.
Reynolds NP; Adamcik J; Berryman JT; Handschin S; Zanjani AAH; Li W; Liu K; Zhang A; Mezzenga R
Nat Commun; 2017 Nov; 8(1):1338. PubMed ID: 29109399
[TBL] [Abstract][Full Text] [Related]
12. pH-dependent amyloid and protofibril formation by the ABri peptide of familial British dementia.
Srinivasan R; Jones EM; Liu K; Ghiso J; Marchant RE; Zagorski MG
J Mol Biol; 2003 Nov; 333(5):1003-23. PubMed ID: 14583196
[TBL] [Abstract][Full Text] [Related]
13. Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation.
Ramachandran G; Milán-Garcés EA; Udgaonkar JB; Puranik M
Biochemistry; 2014 Oct; 53(41):6550-65. PubMed ID: 25284680
[TBL] [Abstract][Full Text] [Related]
14. Effect of environmental conditions on aggregation and fibril formation of barstar.
Gast K; Modler AJ; Damaschun H; Kröber R; Lutsch G; Zirwer D; Golbik R; Damaschun G
Eur Biophys J; 2003 Dec; 32(8):710-23. PubMed ID: 12898068
[TBL] [Abstract][Full Text] [Related]
15. Formation of amyloid fibrils in vitro from partially unfolded intermediates of human gammaC-crystallin.
Wang Y; Petty S; Trojanowski A; Knee K; Goulet D; Mukerji I; King J
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):672-8. PubMed ID: 19684009
[TBL] [Abstract][Full Text] [Related]
16. Evidence for stepwise formation of amyloid fibrils by the mouse prion protein.
Jain S; Udgaonkar JB
J Mol Biol; 2008 Oct; 382(5):1228-41. PubMed ID: 18687339
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous acquisition of infrared, fluorescence and light scattering spectra of proteins: direct evidence for pre-fibrillar species in amyloid fibril formation.
Baldassarre M; Bennett M; Barth A
Analyst; 2016 Feb; 141(3):963-73. PubMed ID: 26668843
[TBL] [Abstract][Full Text] [Related]
18. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.
Sandberg A; Luheshi LM; Söllvander S; Pereira de Barros T; Macao B; Knowles TP; Biverstål H; Lendel C; Ekholm-Petterson F; Dubnovitsky A; Lannfelt L; Dobson CM; Härd T
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15595-600. PubMed ID: 20713699
[TBL] [Abstract][Full Text] [Related]
19. Dual role of an N-terminal amyloidogenic mutation in apolipoprotein A-I: destabilization of helix bundle and enhancement of fibril formation.
Adachi E; Nakajima H; Mizuguchi C; Dhanasekaran P; Kawashima H; Nagao K; Akaji K; Lund-Katz S; Phillips MC; Saito H
J Biol Chem; 2013 Jan; 288(4):2848-56. PubMed ID: 23233678
[TBL] [Abstract][Full Text] [Related]
20. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
